Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws

By LabMedica International staff writers
Posted on 30 Jul 2025

Diagnosing elevated uric acid (UA) levels—an important indicator for conditions like gout, chronic kidney disease, and metabolic syndrome—typically requires blood draws, lab equipment, trained technicians, and expensive reagents. More...

These conventional diagnostic methods are invasive, time-consuming, and inaccessible for daily monitoring or use in remote settings. Patients often lack affordable, non-invasive options for quick UA screening at home. Now, researchers have developed a paper-based test that provides instant, lab-free detection of UA levels using just a drop of saliva and a smartphone.

Scientists from Shaanxi University of Science and Technology (Xi'an, China) have created “abnormal UA alarm,” a paper strip embedded with naphthylimide-derived fluorescent microparticles (NIFS) anchored to cellulose fibers. In water, these particles self-assemble into glowing lamellar structures under UV light, which dim proportionally when uric acid is present due to hydrogen bonding between the dye and UA. The darker the fluorescence, the higher the uric acid concentration. A smartphone app captures the color shift and calculates UA concentration by reading changes in the green channel of RGB values. The strip is entirely enzyme-free, electricity-independent, and integrates with a compact, credit-card-sized dark box that snaps onto smartphones, making the device user-friendly and highly portable.

A laboratory validation study, published in the Journal of Bioresources and Bioproducts, showed that the test detects UA concentrations as low as 0.91 μmol/L—well below the 250 μmol/L salivary threshold linked to hyperuricemia. Even when exposed to 34 common interferents like salts, amino acids, glucose, and dopamine, the strip’s fluorescence change remained UA-specific. In tests using real saliva, artificial urine, and food extracts, the tool yielded results with 95% to 108% accuracy, matching traditional hospital assays. The strips are stable for at least six months at room temperature and cost less than one U.S. cent to produce. Researchers aim to launch an open-source testing kit later this year, with applications envisioned for use in homes, pharmacies, gyms, and low-resource clinics.

Related Links:
Shaanxi University of Science and Technology


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.